Histone hyperacetylation is associated with amelioration of experimental colitis in mice
- PMID: 16585598
- DOI: 10.4049/jimmunol.176.8.5015
Histone hyperacetylation is associated with amelioration of experimental colitis in mice
Abstract
Inhibitors of histone deacetylases (HDAC) are being studied for their antiproliferative effects in preclinical cancer trials. Recent studies suggest an anti-inflammatory role for this class of compounds. Because inflammatory bowel disease is associated with an increased risk of malignancies, agents with antiproliferative and anti-inflammatory properties would be of therapeutic interest. HDAC inhibitors from various classes were selected and evaluated for their in vitro capacity to suppress cytokine production and to induce apoptosis and histone acetylation. Valproic acid (VPA) and suberyolanilide hydroxamic acid (SAHA) were chosen for further studies in dextran sulfate sodium- and trinitrobenzene sulfonic acid-induced colitis in mice. In vitro, inhibition of HDAC resulted in a dose-dependent suppression of cytokine synthesis and apoptosis induction requiring higher concentrations of HDAC inhibitors for apoptosis induction compared with cytokine inhibition. Oral administration of either VPA or SAHA reduced disease severity in dextran sulfate sodium-induced colitis. The macroscopic and histologic reduction of disease severity was associated with a marked suppression of colonic proinflammatory cytokines. In parallel to the beneficial effect observed, a dose-dependent increase in histone 3 acetylation at the site of inflammation was shown under VPA treatment. Furthermore, SAHA as well as VPA treatment resulted in amelioration of trinitrobenzene sulfonic acid-induced colitis, which was associated with an increase of apoptosis of lamina propria lymphocytes. Inhibitors of HDAC reveal strong protective effects in different models of experimental colitis by inducing apoptosis and suppressing proinflammatory cytokines, thereby representing a promising class of compounds for clinical studies in human inflammatory bowel disease.
Similar articles
-
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice.Gut. 2008 May;57(5):613-22. doi: 10.1136/gut.2007.134650. Epub 2008 Jan 14. Gut. 2008. PMID: 18194985
-
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.Int J Oncol. 2007 Sep;31(3):633-41. Int J Oncol. 2007. PMID: 17671692
-
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.Epigenetics. 2013 Feb;8(2):210-9. doi: 10.4161/epi.23538. Epub 2013 Jan 15. Epigenetics. 2013. PMID: 23321683 Free PMC article.
-
Inhibition of histone deacetylases in inflammatory bowel diseases.Mol Med. 2011 May-Jun;17(5-6):426-33. doi: 10.2119/molmed.2011.00069. Epub 2011 Feb 22. Mol Med. 2011. PMID: 21365125 Free PMC article. Review.
-
The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies.Cancer Treat Rev. 2016 Feb;43:58-66. doi: 10.1016/j.ctrv.2015.04.003. Epub 2015 Apr 9. Cancer Treat Rev. 2016. PMID: 26827693 Review.
Cited by
-
Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice.J Dermatol Sci. 2012 Nov;68(2):99-107. doi: 10.1016/j.jdermsci.2012.09.001. Epub 2012 Sep 7. J Dermatol Sci. 2012. PMID: 22999682 Free PMC article.
-
Histone Deacetylase Isoforms Differentially Modulate Inflammatory and Autoantibody Responses in a Mouse Model of Myasthenia Gravis.Front Neurol. 2022 Feb 10;12:804113. doi: 10.3389/fneur.2021.804113. eCollection 2021. Front Neurol. 2022. PMID: 35222229 Free PMC article.
-
Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model.Life Sci Alliance. 2018 Sep 24;1(5):e201800039. doi: 10.26508/lsa.201800039. eCollection 2018 Oct. Life Sci Alliance. 2018. PMID: 30456376 Free PMC article.
-
Effects of caloric restriction on the gut microbiome are linked with immune senescence.Microbiome. 2022 Apr 4;10(1):57. doi: 10.1186/s40168-022-01249-4. Microbiome. 2022. PMID: 35379337 Free PMC article.
-
Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.Diabetologia. 2018 Feb;61(2):389-398. doi: 10.1007/s00125-017-4459-0. Epub 2017 Oct 13. Diabetologia. 2018. PMID: 29030662
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources